After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
TCRT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $0.14 and fluctuated between $0.1377 as its day high and $0.1220 as its day low. The current market capitalization of Alaunos Therapeutics Inc is $33.06M. A total of 1.32 million shares were traded on the day, compared to an average of 6.82M shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, TCRT has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 1 SELLs from insiders. Insiders purchased 0 shares during that period but sold 68,014.
In the most recent transaction, Boyle Kevin S. Sr. sold 68,014 shares of TCRT for 0.14 per share on Sep 01. After the transaction, the Chief Executive Officer now owns 798,236 company shares.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for TCRT in the last 3 months, the mean price target is $7.50 with high estimates of $7.50 and low estimates of $7.50. In terms of 52-week highs and lows, TCRT has a high of $0.85 and a low of $0.04.
As of this writing, TCRT has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.03 per share and a lower estimate of -$0.03.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. TCRT’s latest balance sheet shows that the firm has $76.05M in Cash & Short Term Investments as of fiscal 2021. There were $29.36M in debt and $16.04M in liabilities at the time. Its Book Value Per Share was $0.06, while its Total Shareholder’s Equity was $58.06M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TCRT is Buy with a score of 3.00.
